Latest Schedule 13G passive stakes

NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.02% in Estee Lauder Companies Inc., holding over 12.4 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of over 5.24% in Dollar General Corp., holding 11,569,896 shares as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a 4.97% stake in Encompass Health Corp., holding 4,935,748 shares as of June 30, 2026.
NYSE
Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 8,913,994 shares of HF Sinclair Corp. common stock, representing 4.94% of the class.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 1,960,312 shares, representing 5.06% of Evercore Inc.'s common stock, as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.42% of Ashland Inc.'s common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.02% of Ormat Technologies Inc. common stock as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 4.53% stake in Arrowhead Pharmaceuticals Inc., holding over 6.38 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 4.98% in Graphic Packaging Holding Co. as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership stake of 5.03% in Goodyear Tire & Rubber Co., as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 4,137,941 shares of HealthEquity Inc. common stock, representing 4.94% of the class.
NYSE
Vanguard Portfolio Management has reported a 4.9% stake in Lithia Motors Inc., holding over 1.1 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.75% in Capri Holdings Ltd, holding over 6.6 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership stake of 5.28% in Darling Ingredients Inc., holding over 8.39 million shares.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.21% of KB Home's common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 4.94% of Macy's Inc. common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.38% in Harley-Davidson Inc. common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.03% of Kirby Corp's common stock as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 4.91% stake in Ensign Group Inc. as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 4.97% in H&R Block Inc. common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 6.14% in Genpact Ltd, holding over 10.4 million shares.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 5.11% of Marzetti Company's common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.05% in Knife River Corp, holding 2,870,086 shares as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a 4.38% stake in DigitalOcean Holdings Inc., holding 4,575,728 shares as of June 30, 2026.
NYSE
Vanguard Portfolio Management has filed a Schedule 13G, reporting beneficial ownership of 4.94% of Equitable Holdings Inc. common stock as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 4.97% stake in Nutanix Inc., holding over 13.4 million shares.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership stake of 5.06% in Lantheus Holdings Inc., as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 5.31% stake in ACM Research Inc., holding over 3.4 million shares.
NASDAQ
Vanguard Capital Management has reported a 4.44% stake in Zillow Group Inc. as of June 30, 2026.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.11% of Zevra Therapeutics Inc. common stock as of June 30, 2026.